| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |